CD8A and neoplasm: By lysing subcutaneously engineered bacteria, epidermal Langerhans cells further present tumour peptides in MHC molecules for T-cell priming, and then distant primed CD8+ T cells enter the circulation and infiltrate into tumours for cytotoxicity.